📋 Landos Biopharma, Inc. (LABP) - Executive Changes
Filing Date: 2022-06-21
Accepted: 2022-06-21 16:20:08
Event Type: Executive Changes
Event Details:
Landos Biopharma Inc (was acquired by AbbVie Inc. (NYSE: ABBV) on 25/03/2024) (LABP) Announces Executive and Board Changes
Landos Biopharma Inc (was acquired by AbbVie Inc. (NYSE: ABBV) on 25/03/2024) (LABP) announced changes to its leadership team and board of directors.
Gregory Oakes was appointed. The position includes: Class I. The change is effective as of June 18, 2022.
Executive Changes Details:
Personnel Involved: Gregory Oakes
Actions: Appointed, Departed
Board Classification: Class I
👥 Executive & Board Changes:
Personnel Involved: Gregory Oakes
Actions: Appointed, Departed
Effective Dates: June 18, 2022, June 20, 2022, June 17, 2022, June 30, 2022, June 7, 2023, June 21, 2022
💼 Business Developments:
Partnership
Acquisition
Licensing: Not available
Regulatory Approval: Not available
Executive Changes
Structured Data:
Company Name: Landos Biopharma Inc (was acquired by AbbVie Inc. (NYSE: ABBV) on 25/03/2024)
📋 Landos Biopharma, Inc. (LABP) - Executive Changes
Filing Date: 2022-06-21
Accepted: 2022-06-21 16:20:08
Event Type: Executive Changes
Event Details:
👥 Executive & Board Changes:
💼 Business Developments:
Structured Data: